Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Leukemia 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Lymphoma 40Myelodysplastic Syndromes 30Lymphoma, Non-Hodgkin 29Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Follicular 27Leukemia, Myeloid, Acute 26Leukemia, Myeloid, Chronic-Phase 25Leukemia, Lymphocytic, Chronic, B-Cell 24Burkitt Lymphoma 24Leukemia, Myeloid, Accelerated Phase 23Lymphoma, Large-Cell, Immunoblastic 22Multiple Myeloma 20Hodgkin Disease 20Myeloproliferative Disorders 19Lymphoma, Mantle-Cell 18Lymphoma, B-Cell, Marginal Zone 18Graft vs Host Disease 18Blast Crisis 18Neoplasms, Plasma Cell 17Leukemia, Myelomonocytic, Chronic 16Dendritic Cell Sarcoma, Interdigitating 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 14Congenital Abnormalities 14Recurrence 13Anemia, Refractory, with Excess of Blasts 13Primary Myelofibrosis 12Myelodysplastic-Myeloproliferative Diseases 12Lymphoma, T-Cell, Cutaneous 10

Interventions

Cisplatin 7Etoposide 6Amifostine 6Radiotherapy 5Drug Therapy 5Cyclophosphamide 5apatinib 4Methotrexate 4Filgrastim 4Cytarabine 4sodium thiosulfate 3Methylprednisolone 3Carboplatin 3pegfilgrastim 2glucarpidase 2etoposide phosphate 2Voriconazole 2Vincristine 2Social Determinants of Health 2Pyridoxine 2Nivolumab 2Gemcitabine 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Capecitabine 2trastuzumab deruxtecan 1selinexor 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Drug-Related Side Effects and Adverse Reactions × Methylprednisolone × Clear all
NCT07554885 2026-05-26

Nutritional + Usual Corticosteroids Randomized Trial for Immune-Related pneumoniA - Therapeutic Utilization Evaluation

Guangzhou Institute of Respiratory Disease

Phase NA Not yet recruiting
60 enrolled

Neoplasms, Pneumonia, Drug-Related Side Effects and Adverse Reactions

NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Massachusetts General Hospital

Phase 2 Active not recruiting
42 enrolled
Dermatologic

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡